6.1 Brevetto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.682
EU - Europa 5.594
AS - Asia 4.170
SA - Sud America 363
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 1
Totale 16.860
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.623
IT - Italia 1.553
CN - Cina 1.387
SE - Svezia 1.134
SG - Singapore 1.019
IE - Irlanda 760
KR - Corea 684
RU - Federazione Russa 567
TR - Turchia 520
DE - Germania 470
UA - Ucraina 380
BR - Brasile 333
GB - Regno Unito 279
HK - Hong Kong 249
VN - Vietnam 167
FI - Finlandia 143
CH - Svizzera 114
AT - Austria 47
FR - Francia 36
CA - Canada 34
IN - India 33
AE - Emirati Arabi Uniti 21
EU - Europa 21
NL - Olanda 19
AL - Albania 18
BD - Bangladesh 17
BE - Belgio 17
ES - Italia 17
MX - Messico 17
PL - Polonia 17
ZA - Sudafrica 14
AR - Argentina 11
IQ - Iraq 11
PK - Pakistan 11
JP - Giappone 10
LT - Lituania 8
UZ - Uzbekistan 6
EC - Ecuador 5
MA - Marocco 5
PE - Perù 5
VE - Venezuela 5
SA - Arabia Saudita 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
ID - Indonesia 3
IL - Israele 3
KG - Kirghizistan 3
TT - Trinidad e Tobago 3
EG - Egitto 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
ME - Montenegro 2
MY - Malesia 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BJ - Benin 1
CL - Cile 1
CR - Costa Rica 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
IM - Isola di Man 1
IS - Islanda 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UG - Uganda 1
Totale 16.860
Salva come PNG Salva come JPEG
Città #
Pisa 981
Jacksonville 864
Dublin 760
Chandler 751
Dallas 737
Seoul 683
Ashburn 498
Boardman 468
Izmir 404
Singapore 386
Wilmington 365
Ann Arbor 328
Beijing 296
Hefei 253
Hong Kong 244
Düsseldorf 185
Boston 179
Millbury 176
Moscow 162
Dong Ket 150
Kent 117
San Mateo 116
Mestre 108
Istanbul 106
Bern 92
Seattle 87
Woodbridge 85
Los Angeles 83
Dearborn 79
Bremen 76
Lawrence 71
The Dalles 69
New York 68
Ogden 66
Scuola 65
Milan 59
Princeton 55
Chicago 44
Guangzhou 43
Saint Petersburg 43
Vienna 41
San Giuliano Terme 39
Munich 38
Buffalo 32
Santa Clara 30
Shanghai 30
São Paulo 28
Rome 24
Council Bluffs 23
North Bergen 22
Nanjing 21
Padova 21
Wuhan 21
Brooklyn 18
Helsinki 18
Kunming 18
Zurich 18
Washington 17
Brussels 16
Warsaw 16
Orem 15
Andover 14
Jiaxing 14
Montreal 14
Norwalk 14
Brescia 13
Jinan 13
Toronto 13
Turku 13
Bientina 12
Chennai 12
Florence 12
Poplar 12
Yiwu 12
Cambridge 11
Fairfield 11
Frankfurt am Main 11
Johannesburg 10
London 10
Manchester 10
Phoenix 10
San Francisco 10
Tokyo 10
Wuxi 10
Denver 9
Ho Chi Minh City 9
Houston 9
Mexico City 9
Nuremberg 9
Rio de Janeiro 9
Stockholm 9
Atlanta 8
Changsha 8
Hangzhou 8
Nanchang 8
San Diego 8
Ankara 7
Chengdu 7
Curitiba 7
Joinville 7
Totale 11.310
Salva come PNG Salva come JPEG
Nome #
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 276
METODO PER ANIMARE SULLO SCHERMO DI UN COMPUTER UNA PENNA VIRTUALE CHE SCRIVE E DISEGNA 269
Liquid motion control device for Lab-on-a-Chip (LOC) system of e.g. food analysis apparatus, has control unit with acoustic resonator that reflects surface acoustic wave (SAW) when quantity of liquid is present within acoustic resonator 266
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 256
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 251
Composti particolarmente catalizzatori di poliuretani 246
Dispositivo automatizzato per la riabilitazione motoria e per la valutazione della funzionalità degli arti anteriori in modelli animali 233
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 221
Method and device for measuring position and mass 219
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 216
Superfici funzionali con morfologia controllata sulla scala nanometrica atte a modulare l’adesione, vitalità e proliferazione di cellule 213
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 205
NACYLUREA COMPOUNDS FOR PREPARING POLYURETHANES 203
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 196
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 190
Laser circolari a semiconduttore con reticoli per emissione verticale 190
Vettore per il rilascio di un agente attivo, fotoscindibile per irraggiamento nel visibile 188
Bucket brigade address decoding architecture for classical and quantum random access memories 182
Metodo non invasivo per misurare il contenuto idrico assoluto di una foglia 179
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 175
Determinazione dell'organizzazione supramolecolare di molecole incapsulate tramite analisi del tempo di vita della luminescenza 162
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 162
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 159
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 158
Nanoresonator structure used as nanosensor for e.g. medical application, comprises conductive material layers and dielectric layer, and is represented by specific circuit with resonant frequency determined by geometrical dimensions 157
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 155
Method for Ensuring privacy while querying a database by using quantum superpositions and multiple responses 153
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 153
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 153
Method for the humanization of antibodies and humanized antibodies thereby obtained 152
INTRACELLULAR ANTIBODIES 152
Method for the humanization of antibodies and humanized antibodies thereby obtained 150
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 149
Method for the potentiation of opioid analgesics effects on pain 148
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 148
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 147
Method for the humanization of antibodies and humanized antibodies thereby obtained. 143
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 143
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 142
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 140
Humanized anti-NGF antibodies 139
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 139
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 138
Method for the humanization of antibodies and humanized antibodies thereby obtained. 137
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT. 137
Selection of intracellular immunoglobulins 137
Method for the potentiation of opioid analgesics effects on pain 136
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 135
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 135
Intracellular selection 135
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 134
Method for the humanization of antibodies and humanized antibodies thereby obtained 134
Novel analgesic treatment with prolonged effect 133
Intracellular selection 133
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 133
Humanized anti-NGF antibodies 133
Method of identifying a consensus sequence for intracellular antibodies 133
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 132
Intracellular selection 132
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 132
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 131
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 130
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 130
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 130
null 129
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 128
NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS 128
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 128
Novel analgesic treatment with prolonged effect 127
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 127
SEQUENZE CONSENSO PER ANTICORPI INTRACELLULARI E LORO USO 126
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 126
Selection of intracellular immunoglobulins 126
TRANSGENIC MICE FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 126
Selection of intracellular immunoglobulins 126
INTRACELLULAR ANTIBODIES 126
Selection of intracellular immunoglobulins 125
Humanized anti-NGF antibodies 124
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 124
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 124
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 124
Method for the humanization of antibodies and humanized antibodies thereby obtained. 123
Selection of intracellular immunoglobulins 123
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 123
Molecules that are able to inhibit the binding between NGF and the Trka receptor as analgesics with prolonged effect 122
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 122
Non-human transgenic animals for the study of neurodegenerative syndromes 121
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 121
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 121
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 121
Method for the humanization of antibodies and humanized antibodies thereby obtained. 120
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 120
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 119
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 119
Method for the potentiation of opioid analgesics effects on pain 118
Method for the humanization of antibodies and humanized antibodies thereby obtained 118
Method for the humanization of antibodies and humanized antibodies thereby obtained. 118
METHOD OF IDENTIFYING A CONSENSUS SEQUENCE FOR INTRACELLULAR ANTIBODIES 118
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 118
INTRACELLULAR ANTIBODIES 117
Totale 15.044
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.119 0 0 0 0 0 153 82 123 134 268 91 268
2021/2022928 123 0 24 125 15 5 10 70 50 58 19 429
2022/20233.520 241 136 136 219 161 380 0 982 1.122 22 38 83
2023/20241.181 209 48 93 31 53 127 18 119 199 22 19 243
2024/20253.265 93 34 178 172 477 14 42 188 657 153 603 654
2025/20263.288 556 671 988 697 302 74 0 0 0 0 0 0
Totale 17.003